严重急性呼吸综合征冠状病毒2（SARS-CoV-2）大流行对产碳青霉烯酶肺炎克雷伯菌防控计划的影响：趋同还是分歧行动？ - Suppr

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

作者信息

Belvisi V, Del Borgo C, Vita S, Redaelli P, Dolce P, Pacella D, Kertusha B, Carraro A, Marocco R, De Masi M, Mastroianni C, Lichtner M

机构信息

Infectious Diseases Unit, S.M. Goretti Hospital, Latina, Italy.

出版信息

J Hosp Infect. 2021 Mar;109:29-31. doi: 10.1016/j.jhin.2020.11.030. Epub 2020 Dec 15.

DOI:10.1016/j.jhin.2020.11.030

PMID:33338560

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7833704/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ea7/7833704/b55b7e8ed882/gr1_lrg.jpg

相似文献

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

J Hosp Infect. 2021 Mar;109:29-31. doi: 10.1016/j.jhin.2020.11.030. Epub 2020 Dec 15.

A one-year survey of carbapenemase-producing Klebsiella pneumoniae in Italy: beyond the ICU.

Clin Microbiol Infect. 2015 Feb;21(2):e11-3. doi: 10.1016/j.cmi.2014.09.012. Epub 2014 Oct 29.

Outbreak of NDM-1-producing Klebsiella pneumoniae in the intensive care unit during the COVID-19 pandemic: Another nightmare.

Am J Infect Control. 2021 Oct;49(10):1324-1326. doi: 10.1016/j.ajic.2021.07.004. Epub 2021 Jul 15.

Outbreak of infection with Klebsiella pneumoniae sequence type 258 producing Klebsiella pneumoniae Carbapenemase 3 in an intensive care unit in Italy.

J Clin Microbiol. 2010 Apr;48(4):1506-7. doi: 10.1128/JCM.00315-10. Epub 2010 Mar 3.

Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital.

Int J Antimicrob Agents. 2021 Jan;57(1):106245. doi: 10.1016/j.ijantimicag.2020.106245. Epub 2020 Nov 27.

Emergence of KPC-2 carbapenemase-producing Klebsiella pneumoniae strains and spread of an isolate of sequence type 258 in the neuro-rehabilitation unit of an Italian hospital.

J Chemother. 2010 Jun;22(3):212-4. doi: 10.1179/joc.2010.22.3.212.

Isolation of OXA-181 Carbapenemase-Producing Escherichia coli and OXA-232 Carbapenemase-Producing Klebsiella pneumoniae from a Pregnant Woman Returning to Japan from India.

Jpn J Infect Dis. 2019 Jul 24;72(4):281-283. doi: 10.7883/yoken.JJID.2018.432. Epub 2019 May 31.

Klebsiella pneumoniae carbapenemase-producing Klebsiella pneumoniae in the intensive care unit: a real challenge to physicians, scientific community, and society.

Shock. 2013 May;39 Suppl 1:32-7. doi: 10.1097/SHK.0b013e31828faf1f.

Successful eradication of a monoclonal strain of Klebsiella pneumoniae during a K. pneumoniae carbapenemase-producing K. pneumoniae outbreak in a surgical intensive care unit in Miami, Florida.

Infect Control Hosp Epidemiol. 2010 Oct;31(10):1074-7. doi: 10.1086/656243.

Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae.

J Infus Nurs. 2010 May-Jun;33(3):150-4. doi: 10.1097/NAN.0b013e3181d9c5ab.

引用本文的文献

Containment of a carbapenem-resistant in an intensive care unit during the COVID-19 pandemic.

Front Public Health. 2025 Jun 17;13:1557068. doi: 10.3389/fpubh.2025.1557068. eCollection 2025.

Analysis of the potentially pathogenic bacteria of lower respiratory tract infections in children per-, during and post-COVID-19: a retrospective study.

Eur J Clin Microbiol Infect Dis. 2025 Jan;44(1):167-180. doi: 10.1007/s10096-024-04991-9. Epub 2024 Nov 18.

Carbapenem-Resistant in COVID-19 Era-Challenges and Solutions.

Antibiotics (Basel). 2023 Aug 4;12(8):1285. doi: 10.3390/antibiotics12081285.

Antibiotic resistance associated with the COVID-19 pandemic: a systematic review and meta-analysis.

Clin Microbiol Infect. 2023 Mar;29(3):302-309. doi: 10.1016/j.cmi.2022.12.006. Epub 2022 Dec 9.

Overuse of empirical antibiotics in a COVID-19 intensive care unit led to the spread of carbapenem-resistant Gram-negative bacteria in a teaching hospital.

J Glob Antimicrob Resist. 2022 Sep;30:100-102. doi: 10.1016/j.jgar.2022.06.006. Epub 2022 Jun 13.

The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens.

Front Cell Infect Microbiol. 2022 Mar 17;12:823626. doi: 10.3389/fcimb.2022.823626. eCollection 2022.

Comparison of Six Phenotypic Assays with Reference Methods for Assessing Colistin Resistance in Clinical Isolates of Carbapenemase-Producing Enterobacterales: Challenges and Opportunities.

Antibiotics (Basel). 2022 Mar 11;11(3):377. doi: 10.3390/antibiotics11030377.

Repatriation of a patient with COVID-19 contributed to the importation of an emerging carbapenemase producer.

J Glob Antimicrob Resist. 2021 Dec;27:267-272. doi: 10.1016/j.jgar.2021.10.012. Epub 2021 Oct 28.

Diagnostic, Clinical and Post-SARS-CoV-2 Scenarios in Cancer Patients with SARS-CoV-2: Retrospective Analysis in Three German Cancer Centers.

Cancers (Basel). 2021 Jun 11;13(12):2917. doi: 10.3390/cancers13122917.

Carbapenem-Resistant Infections in ICU COVID-19 Patients-A Scoping Review.

J Clin Med. 2021 May 12;10(10):2067. doi: 10.3390/jcm10102067.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Impact of SARS CoV-2 pandemic on carbapenemase-producing Klebsiella pneumoniae prevention and control programme: convergent or divergent action?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献